Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?
One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. Let’s put Cigna Corporation CI stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks:
PE Ratio
A key metric that value investors always look at is the Price to Earnings Ratio, or PE for short. This shows us how much investors are willing to pay for each dollar of earnings in a given stock, and is easily one of the most popular financial ratios in the world. The best use of the PE ratio is to compare the stock’s current PE ratio with: a) where this ratio has been in the past; b) how it compares to the average for the industry/sector; and c) how it compares to the market as a whole.
On this front, Cigna Corporation has a trailing twelve months PE ratio of 13.18, as you can see in the chart below:
This level actually compares favorably with the market at large, as the PE for the S&P 500 stands at about 19.5. If we focus on the long-term PE trend, Cigna Corporation’s current PE level puts it below its midpoint of 15.70 over the past five years, with the number having risen rapidly over the past few months. However, the current level stands below the highs for the stock, suggesting that it can be a solid entry point.
Moreover, the stock’s PE also compares favorably with the Zacks Finance Market sector’s trailing twelve months PE ratio, which stands at 14.37. At the very least, this indicates that the stock is relatively undervalued right now, compared to its peers.
We should also point out that Cigna Corporation has a forward PE ratio (price relative to this year’s earnings) of 12.04, so it is fair to say that a slightly more value-oriented path may be ahead for Cigna Corporation’s stock in the near term too.
P/S Ratio
Another key metric to note is the Price/Sales ratio. This approach compares a given stock’s price to its total sales, where a lower reading is generally considered better. Some people like this metric more than other value- focused ones because it looks at sales, something that is far harder to manipulate with accounting tricks than earnings.
Right now, Cigna Corporation has a P/S ratio of about 0.59. This is much lower than the S&P 500 average, which comes in at 3.37 right now. Also, as we can see in the chart below, this is well below the highs for this stock in particular over the past few years.
Broad Value Outlook
In aggregate, Cigna Corporation currently has a Value Score of B, putting it into the top 40% of all stocks we cover from this look. This makes Cigna Corporation a solid choice for value investors.
For example, the PEG ratio for Cigna Corporation is just 1.03, a level that is lower than the industry average of 1.18. The PEG ratio is a modified PE ratio that takes into account the stock’s earnings growth rate. Clearly, CI is a solid choice on the value front from multiple angles.
What About the Stock Overall?
Though Cigna Corporation might be a good choice for value investors, there are plenty of other factors to consider before investing in this name. In particular, it is worth noting that the company has a Growth Score of A and Momentum Score of F. This gives CI a Zacks VGM score — or its overarching fundamental grade — of B. (You can read more about the Zacks Style Scores here >>)
Meanwhile, the company’s recent earnings estimates have been mixed at the best. The current year has seen 12 upward revisions in the past sixty days compared to no downward revisions, while the full year 2020 estimate has seen three upward revision compared to eight downward revisions in the same time period.
The current year consensus estimate increased 0.95% in the past two months, whereas the full year 2020 estimate fell 0.43%. You can see the consensus estimate trend and recent price action for the stock in the chart below:
Cigna Corporation Price and Consensus
Owing to such bearish estimate trends, the stock has a Zacks Rank #3 (Hold), which is why we are looking for in-line performance from the company in the near term.
Bottom Line
Cigna Corporation is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front. However, with a sluggish industry rank (bottom 34% out of more than 250 industries) and a Zacks Rank #3, it is hard to get too excited about this company overall. In fact, over the past two years, the broader industry has underperformed the market at large, as you can see below:
So, value investors might want to wait for estimates and analyst sentiment to turn around in this name first, but once that happens, this stock could be a compelling pick.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment